Novo Nordisk Medications - Search News

Novo Nordisk, drug Wegovy

Reuters on MSN · 2h

Novo Nordisk's new obesity drug trial data disappoints again

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate CagriSema, knocking shares and stoking worries that rival Eli Lilly may be gaining an edge over the company in the weight-loss drugs market.

Fox Business on MSN · 4h

Novo Nordisk shares fall on weight-loss drug trial

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

USA TODAY on MSN · 4d

Wegovy price cut: Novo Nordisk cuts the price of the weight-loss drug for the uninsured

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight-loss drug Wegovy.

2h

Novo Nordisk stock slides Monday on second-generation GLP-1 data

Novo Nordisk ( NVO) stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its ...

2hon MSN

The State of Weight Loss Drugs

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

GlobalData on MSN4d

Novo Nordisk cuts Wegovy price through new direct-to-patient online pharmacy

The Danish drugmaker has launched a new online pharmacy called NovoCare Pharmacy to cut out the middlemen it so frequently ...

Obesity medication: Novo Nordisk to sell Wegovy directly to patients at lower price

Novo Nordisk has announced the launch of NovoCare Pharmacy, a new initiative that will offer its weight-loss drug Wegovy ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results